Drug Targeting by Diagnostic Ultrasound Contrast - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Drug Targeting by Diagnostic Ultrasound Contrast
Microbubbles can temporarily open many biological barriers for polar molecules, macromolecules, and particles. Scientists have brought well-known contrast agents back to the laboratory and redesigned them as drug carriers.


Pharmaceutical Technology


References

1. C. Mayer and R. Bekeredjian, Adv. Drug Deliv. Rev. 60 (10), 1177–1192 (2008).

2. S. Tinkov et al., J. Pharm. Sci. 98 (6), 1935–1961 (2009).

3. P. Li, W.F. Armstrong, and D.L. Miller, Ultrasound Med. Biol. 30 (1), 83–91 (2004).

4. J. Song et al., J. Am. Coll. Cardiol. 39 (4), 726–731 (2002).

5. M.A. Borden et al., Langmuir 23 (18), 9401–9408 (2007).

6. R. Bekeredjian et al., Circulation 108,1022–1026 (2003).

7. R. Bekeredjian et al., Ultrasound Med. Biol. 31 (5), 687–691 (2005).

8. S. Tinkov et al., J. Control. Release 143 (1), 143–150 (2010).

9. J. Kang, J. Ultrasound Med. 29 (1), 61–70 (2010).

10. E.C. Unger et al., Acad. Radiol. 5 (10), 247–249 (1998).

11. M.S. Tartis et al., Ultrasound Med. Biol. 32 (11), 1771–1780 (2006).

12. J.Y. Fang et al., Eur. J. Pharm. Biopharm. 67 (1), 67–75 (2007).

13. S. Tinkov, Development of Ultrasound Contrast Agents for Targeted Drug and Gene Delivery (Verlag Dr. Hut, Munich, 2009).

14. I. Lentacker, "Design and Evaluation of Drug-Loaded Microbubbles for Ultrasound-Guided Cancer Therapy. Faculty of Pharmaceutical Sciences" (PhD diss., Ghent University, 2009), 216.

15. I. Lentacker et al., Mol. Ther. 18 (1), 101–108 (2010).

16. L.H. Treat et al., Int. J.Cancer 121 (4), 901–907 (2007).

17. R.K. Schlicher et al., Ultrasound Med. Biol. 32 (6), 915–924 (2006).

18. J.R. Eisenbrey et al., J. Control. Release 143 (1), 38–44 (2010).

19. N. Rapoport, Z. Gao, and A. Kennedy, J. Natl. Cancer Inst. 99 (14), 1095–1106 (2007).

20. J.J. Choi, "Noninvasive, Localized, and Transient Brain Drug Delivery Using Focused Ultrasound and Microbubbles" (PhD diss., University of Columbia, 2010), 170.

21. E.E. Konofagou et al., AIP Conference Proceedings (Aix-en-Provence, France, 2010), pp. 172–175.

22. J.M. Erikson, G.L. Freeman, and B. Chandrasekar, J. Mol. Cell. Cardiol. 35 (1), 119–130 (2003).

23. E. Akowuah et al., Gene Ther. 12 (14), 1154–1157 (2005).

24. T.R. Porter et al., Ultrasound Med. Biol. 27 (2), 259–265 (2001).

25. X. Feng et al., Ultrasound Med. Biol. 31 (7), 979–985 (2005).

26. F.M. Asch and N.J. Weissman, Circulation 119 (14), 1956–1961 (2009).

27. S. Seemann et al., Pharm. Res. 19 (3), 250–257 (2002).

28. K. Kooiman et al., J. Control. Release 133 (2), 109–118 (2009).

29. A. Kheirolomoom et al., J. Control. Release 118 (3), 275–284 (2007).

30. M.L. Fabiilli, Ultrasound Medicine Biol. 36 (8), 1364–1375 (2010).

31. K.H. Nam et al., AIP Conference Proceedings (Aix-en-Provence France, 2009), pp. 124–128.

32. S.L. Huang and R.C. MacDonald, Biochim. Biophys. Acta 1665 (1–2), 134–141 (2004).

33. S. Tinkov et al., J. Pharm. Sci. 98 (6), 1935–1961 (2009).


ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
What is the single greatest threat to maintaining manufacturing processes at your facility?
Quality issues
Facility/environment problems
Process development problems
Production equipment downtime
Raw material supply problems
Regulatory restrictions
Business decisions to limit production
Quality issues
100%
Facility/environment problems
0%
Process development problems
0%
Production equipment downtime
0%
Raw material supply problems
0%
Regulatory restrictions
0%
Business decisions to limit production
0%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Praise and Perils for Biotechnology Patent Policy
Risk-Mitigation Strategies in Drug Manufacturing for Emerging Markets
Quality Focus: Ensuring Raw Material Transparency
Advertising of Prescription Drugs  Keeping it Honest and Balanced
Key Ways for Ensuring Global Regulatory Compliance
Source: Pharmaceutical Technology,
Click here